NY State Senate Bill 2023-S2661

Current Bill Status - In Senate Committee Consumer Protection Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 03, 2024	referred to consumer protection
Jan 24, 2023	referred to consumer protection

2023-S2661 (ACTIVE) - Details

Current Committee:: Senate Consumer Protection
Law Section:: General Business Law
Laws Affected:: Amd §520-a, Gen Bus L
Versions Introduced in Other Legislative Sessions:: 2017-2018: S8388
2019-2020: S2398
2021-2022: S5828

2023-S2661 (ACTIVE) - Summary

Relates to the personal information of a credit or debit card holder; adds zip code, e-mail address and home, cell and work telephone numbers to the personal information protected.

2023-S2661 (ACTIVE) - Sponsor Memo

                                 
BILL NUMBER: S2661

SPONSOR: COMRIE
 
PURPOSE:

Establishes the Sickle Cell Treatment Act

 
SUMMARY OF SPECIFIC PROVISIONS:

Section 1 of the bill would set forth that this act shall be known and
may be cited as the "Sickle Cell Treatment Act".

Section 2 amends the public health law by adding a new section 2807-aa
which mandates the Commissioner of the Department of Health to designate
Sickle cell centers for excellence and outpatient treatment centers.

Section 3 amends subdivision 8 of section 3331 of the public health law,
as added by section 7-a of part D of chapter 57 of the laws of 2018
relating to opioid exemption.

Section 4 provides the effective date.

JUSTIFICATION:

Sickle Cell patients experience a multitude of symptoms that can range
from mild to severe. There is little to no awareness of possible ways to
manage these symptoms, which is why centers for excellence (COE), and
outpatient treatment centers are essential.

The Centers of Excellence would serve as a hub for adults and children
alike to have access to professionals that can understand, monitor, and
provide care in the most effective way possible. The COEs would further
serve as leaders to other institutions in the treatment of SCD and would
establish the best practices that could then be used in other healthcare
facilities around the state.

Outpatient hospitals would help reduce the need of sickle cell patients
to check into the emergency room for pain, which is the traditional
response of people who are suffering an SCD pain crisis.  Patients would
have access to readily available services that are designated to help
specifically with SCD pain management and symptoms because outpatient
services would be available in areas where there is sufficient need for
the service. The reduced burden on emergency rooms, especially in times
of health crisis, can help patients and doctors alike.

Pain is a major symptom of Sickle Cell disease (SCD) and one of the
principal reasons that people with SCD go to the emergency room. Pain
experienced by sickle cell patients manifests itself as abrupt and very
debilitating pain in any part of the body. Individuals diagnosed with
sickle cell can begin having pain crises as early as 6 months of age.
This legislation will allow certain sickle cell patients to easily gain
access to opioid therapy. Currently, sickle cell patients are restricted
in being treated with opioids. However, due to the debilitating pain
sickle cell disease patients encounter during crisis, opioid therapy
serves to reduce the pain that patients experience.

 
FISCAL IMPLICATIONS:

To be determined
 
EFFECTIVE DATE:
This act shall take effect immediately.

2023-S2661 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   2661
 
                        2023-2024 Regular Sessions
 
                             I N  S E N A T E
 
                             January 24, 2023
                                ___________
 
 Introduced  by  Sen.  COMRIE -- read twice and ordered printed, and when
   printed to be committed to the Committee on Consumer Protection
 
 AN ACT to amend the general business law, in relation  to  the  personal
   information of a credit or debit card holder
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision 3 of section 520-a of the general business law,
 as amended by chapter 233 of the laws of 2007, is  amended  to  read  as
 follows:
   3. No person, firm, partnership or corporation which accepts credit or
 debit  cards for the transaction of business shall require the credit or
 debit card holder to write OR ELECTRONICALLY  ENTER  on  the  credit  or
 debit  card transaction form, nor shall it write [or], cause to be writ-
 ten, OR ELECTRONICALLY ENTERED on such form or on any attachment  there-
 to,  any  personal identification information, including but not limited
 to the credit or debit card  holder's  address  [or],  ZIP  CODE,  EMAIL
 ADDRESS  OR  telephone  [number]  NUMBERS, INCLUDING HOME, CELL AND WORK
 TELEPHONE NUMBERS, that is not required by  the  credit  or  debit  card
 issuer  to  complete  the  credit  or  debit card transaction; provided,
 however, that the credit or debit card holder's address,  ZIP  CODE  and
 telephone  number  may  be required [on such form or attachment thereto]
 where (i) such  information  is  necessary  for  shipping,  delivery  or
 installation  of  purchased merchandise or for special orders; [or] (ii)
 the person, firm, partnership or corporation processes credit  or  debit
 card  transactions by mailing transaction forms to a designated bankcard
 center for settlement; OR (III) SUCH INFORMATION IS USED SOLELY FOR  THE
 DETECTION,  INVESTIGATION OR PREVENTION OF FRAUD, THEFT, IDENTITY THEFT,
 CRIMINAL ACTIVITY OR ENFORCEMENT OF  TERMS  OF  SALE.  NOTHING  IN  THIS
 SUBDIVISION  SHALL  PREVENT  A PERSON, FIRM OR CORPORATION WHICH ACCEPTS
 CREDIT CARDS OR DEBIT CARDS FROM REQUESTING THAT A CUSTOMER  VOLUNTARILY
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD00403-01-3
 S. 2661                             2

 
 PROVIDE  PERSONAL  IDENTIFICATION  WHERE  THE USE OF SUCH INFORMATION IS
 DISCLOSED TO SUCH CONSUMER.
   §  2.  This  act shall take effect on the ninetieth day after it shall
 have become a law.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S2661

Sponsored By

Current Bill Status - In Senate Committee Consumer Protection Committee

2023-S2661 (ACTIVE) - Details

2023-S2661 (ACTIVE) - Summary

2023-S2661 (ACTIVE) - Sponsor Memo

2023-S2661 (ACTIVE) - Bill Text download pdf

Comments

Senate Bill S2661

Share this bill

Sponsored By

Leroy Comrie

Current Bill Status - In Senate Committee Consumer Protection Committee

2023-S2661 (ACTIVE) - Details

2023-S2661 (ACTIVE) - Summary

2023-S2661 (ACTIVE) - Sponsor Memo

2023-S2661 (ACTIVE) - Bill Text download pdf

Comments